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Neurotransmitter removal from glycine-mediated synapses relies on two sodium-driven
high-affinity plasma membrane GlyTs that control neurotransmitter availability. Mostly
glial GlyT1 is the main regulator of glycine synaptic levels, whereas neuronal GlyT2
promotes the recycling of synaptic glycine and supplies neurotransmitter for presynaptic
vesicle refilling. The GlyTs differ in sodium:glycine symport stoichiometry, showing
GlyT1 a 2:1 and GlyT2 a 3:1 sodium:glycine coupling. Sodium binds to the GlyTs
at two conserved Na+ sites: Na1 and Na2. The location of GlyT2 Na3 site remains
unknown, although Glu650 has been involved in the coordination. Here, we have
used comparative MD simulations of a GlyT2 model constructed by homology to the
crystalized DAT from Drosophila melanogaster by placing the Na3 ion at two different
locations. By combination of in silico and experimental data obtained by biochemical
and electrophysiological analysis of GlyTs mutants, we provide evidences suggesting
the GlyT2 third sodium ion is held by Glu-250 and Glu-650, within a region with robust
allosteric properties involved in cation-specific sensitivity. Substitution of Glu650 in
GlyT2 by the corresponding methionine in GlyT1 reduced the charge-to-flux ratio to the
level of GlyT1 without producing transport uncoupling. Chloride dependence of glycine
transport was almost abolished in this GlyT2 mutant but simultaneous substitution of
Glu250 and Glu650 by neutral amino acids rescued chloride sensitivity, suggesting
that protonation/deprotonation of Glu250 substitutes chloride function. The differential
behavior of equivalent GlyT1 mutations sustains a GlyT2-specific allosteric coupling
between the putative Na3 site and the chloride site.
Keywords: GlyT, hyperekplexia, sodium site, neurotransmitter reuptake, SLC6
Abbreviations: ALX1393, O-[(2-Benzyloxyphenyl-3-flurophenyl)methyl]-L-serine; DAT, dopamine transporter; EL,
external loop; ERev, reversal potential; GBSA, generalized born surface area; GlyT, glycine transporter; HBS, HEPES-buffered
saline; IL, internal loop; LeuTAa, leucine transporter from Aequifex aeolicus; MD, molecular dynamics; MM, molecular
mechanics; MSA, multiple sequence alignment; NSS, neurotransmitter–sodium symporter; RMSD, root-mean-square
deviation; SERT, serotonin transporter; SLC, solute carrier; TM, transmembrane domain.
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INTRODUCTION
Glycine fulfills the fast inhibitory transmission in caudal areas
of the adult central nervous system, and it is involved in
the processing of motor, sensory, and nociceptive information
(Legendre, 2001). In addition, glycine exerts positive modulation
of excitatory transmission acting as a co-agonist of glutamate
on N-methyl-D-aspartate receptors (Johnson and Ascher, 1987).
Clearance of synaptic glycine is accomplished by two specific
plasma membrane GlyTs – GlyT1 and GlyT2 (Aragon and Lopez-
Corcuera, 2003). GlyT1, mainly present in astrocytes, is the
main regulator of glycine synaptic levels (Gomeza et al., 2003a).
The neuronal GlyT2 supplies neurotransmitter for presynaptic
vesicle refilling and promotes the recycling of synaptic glycine at
inhibitory synapses (Rousseau et al., 2008). The absence of GlyT2
function eliminates inhibitory glycinergic neurotransmission
(Gomeza et al., 2003b). In humans, this condition causes
hyperekplexia or startle disease, a rare disorder characterized
by exaggerated startle responses to trivial stimuli that may have
severe consequences due to apnea episodes (Rees et al., 2006;
Gimenez et al., 2012; Arribas-González et al., 2015). Moreover,
GlyTs are modulated by pain mediators and are potential
pharmacological targets for pain therapy (Zeilhofer et al., 2005;
Harvey and Yee, 2013).
GlyT1 and GlyT2 are members of the human SLC6 family of
sodium- and chloride-dependent neurotransmitter transporters
(NSS) together with the GABA, and the monoamine transporters
(Rudnick et al., 2014). GlyTs protein fold was first described in
the leucine transporter from Aquifex aeolicus (LeuTAa, PDB code
2A65) (Yamashita et al., 2005) and contains two topologically
inverted structural repeats of five TMs. The repeats intertwine
to form two bundles that rock one against the other during
transport: a scaffold bundle (TMs 3,4,8,9) and a mobile core
bundle (TMs 1,2,6,7). Thus, the central substrates-binding pocket
gains alternatively access to either side of the membrane via
conformational changes (Jardetzky, 1966; Shi, 2013; Rudnick
et al., 2014). LeuTAa has been presently crystalized in outwardly
facing, occluded, inwardly facing conformations, and in the
presence of several inhibitors (Yamashita et al., 2005; Zhou et al.,
2007, 2009; Singh et al., 2008; Krishnamurthy and Gouaux, 2012).
Later, the eukaryotic transporters for dopamine from Drosophila
melanogaster (dDAT) (Penmatsa et al., 2013, 2015) and for
serotonin from human (hSERT) (Coleman et al., 2016) were
crystalized in inhibitor-bound forms.
Molecular dynamics simulations of GlyT structures modeled
using LeuTAa crystalographic structure as a template predicted
the conservation of the substrate (glycine) and two sodium-
binding sites Na1 and Na2 (Perez-Siles et al., 2012). The use
of these sites by the GlyTs was confirmed through site-directed
mutagenesis and analysis of GlyTs sensitivity to lithium ion
(Perez-Siles et al., 2011, 2012). GlyT1 and GlyT2 differ in their
sodium:glycine symport stoichiometry which is 2:1 for GlyT1 and
3:1 for GlyT2 (Roux and Supplisson, 2000), and this property
is crucial for their unique physiological roles (Gomeza et al.,
2003a,b). A transitory cation binding site was identified in
the extracellular vestibule of GlyT2 (Perez-Siles et al., 2012)
that partially overlaps with a transient Na+-binding site lately
discovered in LeuTAa (Zomot et al., 2015). However, although
a proposal was recently made, the location of the GlyT2 Na3
site remains elusive (Subramanian et al., 2016). The chloride
binding site was predicted to be adjacent to the Na1 site in
the eukaryotic chloride-dependent transporters (Zomot et al.,
2007; Kantcheva et al., 2013; Penmatsa et al., 2013). Still, the
relationship between sodium and chloride sites and the role of
chloride in GlyT2 transport cycle is unsettled. The structural
dynamics and interactions of GlyT2 may provide valuable
information for the study of pathological aspects of GlyTs such
as hyperekplexia.
MATERIALS AND METHODS
GlyTs Mutagenesis and Transporter
Expression
Substitution mutants were generated with the QuikChange
II Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA,
United States), using the rGlyT2 (Liu et al., 1993) subcloned in
pCDNA3 as reported (Arribas-Gonzalez et al., 2013) or rGlyT1
(Smith et al., 1992) in pcDNA3 (Perez-Siles et al., 2012). The
complete coding region of the constructs was sequenced to verify
that only the desired mutation had been introduced. Plasmids
from two independent Escherichia coli colonies were expressed
into eukaryotic cells and [3H]glycine transport was measured
for verification. COS7 cells (American Type Culture Collection,
Rockville, MD, United States) were grown and transfected using
TurboFect Transfection Reagent (Thermo Fisher Scientifics,
Waltham, MA, United States), following the manufacturer’s
protocol (2 µl reagent/µg of DNA). Cells were incubated for 48 h
at 37◦C until used (Arribas-Gonzalez et al., 2015).
Transport Assays
COS7 cells were washed and incubated at 37◦C in HBS (in mM:
150 NaCl, 10 HEPES-Tris, pH 7.4, 1 CaCl2, 5 KCl, 1 MgSO4,
10 glucose) containing 2 µCi/ml [2-3H]glycine (1.6 TBq/mmol;
PerkinElmer Life Sciences, Boston, MA, United States), at
10 µM final glycine concentration if not otherwise stated
(Gimenez et al., 2012). At the end of the desired time (10 min),
reactions were washed and terminated by aspiration. Protein
concentration (Bradford, Biorad, Berkeley, CA, United States)
and [2-3H]glycine (liquid scintillation, Opti-Fluor, PerkinElmer
Life Sciences, Boston, MA, USA, LKB 1219 Rackbeta) were
determined. Glycine accumulation by mock-transfected cells
was subtracted from that of the transporter-transfected cells
and normalized by the protein concentration. Kinetic analyses
were performed by varying glycine concentration in the uptake
medium between 0.5 and 500 µM.
Surface Biotinylation
Cells expressing the transporters were labeled with 1.0 mg/ml
Sulfo-NHS-Biotin (Pierce, Cambrige, MA, United States) in PBS
at 4◦C, as described (Arribas-Gonzalez et al., 2015). Free biotin
quenching was performed by adding 100 mM L-lysine in PBS
and then 1× lysis buffer: in mM, 150 NaCl, 50 Tris-HCl pH 7.4,
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5 EDTA, 0.4 PMSF supplemented with 1% Triton X-100, 0.1%
SDS, 0.25% sodium deoxycholate, and 4 µl/ml protease inhibitor
cocktail (Sigma-Aldrich, St. Louis, MO, United States). A lysate
aliquot was saved (total protein content), and the remainder was
incubated with 50% streptavidin–agarose beads (Sigma-Aldrich,
St. Louis, MO, United States) for 2 h at room temperature
and centrifuged. An aliquot of the supernatant was saved to
quantify the non-biotinylated fraction and the agarose beads were
recovered, washed three times with 1× lysis buffer, and bound
proteins (biotinylated) were eluted with Laemmli buffer (65 mM
Tris, 10% glycerol, 2.3% SDS, 100 mM DTT, 0.01% bromophenol
blue) for 10 min at 75◦C. Samples were analyzed by Western blot
as described (Arribas-Gonzalez et al., 2015).
Homology Modeling of GlyT2
The crystalized DAT from dDAT (PDB code 4M48) (Penmatsa
et al., 2013) was used as the homology model template.
Alignments between the sequence of dDAT and human GlyT2
(Q9Y345.3| SLC6A5_HUMAN) were obtained by profile-profile
alignment using the program Muscle (Edgar, 2004). Profiles for
the protein sequence were obtained by MSA using the program
MAFFT (Katoh et al., 2002). Sequences included in MSAs were
detected by the program blastp (Altschul et al., 1990) against the
NCBI’s nr database, with an e-value below 1e-15. A GlyT2 model
with the bound substrate (glycine) and coupled ions was obtained
using MODELER version 9.13 (Sali and Blundell, 1993). Initial
alignments were iteratively refined based on the evaluation of
obtained model. The modeled region for GlyT2 was from Lys191
to Trp760, excluding the loop between Leu329 and Ala365, which
is not present in dDAT. Mutants were built using the Mutagenesis
Wizard implemented in PyMol (The PyMOL Molecular Graphics
System). Systems setup entailed adding hydrogen atoms, to assign
atom types and charges according to AMBER ff03 force field
(Duan et al., 2003), and to determine the protonation state of
ionizable residues at pH 7 using H++web server1 (Gordon et al.,
2005).
Molecular Dynamics Simulations
The three 3D models (GlyT2-Na3 location 1 model, GlyT2-
Na3 location 2 model, and GlyT2-E650M model) were further
refined by means of MD simulations. Using the Membrane
Builder module (Jo et al., 2007, 2009) in CHARMM-GUI2 (Jo
et al., 2008), each protein was inserted in a pre-equilibrated box
containing a POPC lipid bilayer, POPE lipid bilayer, cholesterol
molecules (in a proportion 2:2:1) covered by water up and
down, and a 0.15-M concentration of Na+ and Cl− ions. We
performed MD simulations using AMBER12 (Case et al., 2012).
The protocol was as follows: (i) energy minimization to relax the
initial model (20 ps); (ii) heating (100 k), holding lipid molecules,
and Cα carbons fixed (100 ps); (iii) heating (300 k), holding
lipid molecules, and Cα carbons fixed (100 ps); (iv) holding, to
equilibrate the water molecules around the solutes (10 × 200 ps,
lowering restraints on lipid molecules and Cα carbons); (v) after
successfully equilibration, production at constant temperature
1http://biophysics.cs.vt.edu/H++
2http://www.charmm-gui.org/
and pressure (50 ns). All the simulations were performed at
constant pressure (1 atm) and temperature (300◦K) with an
integration time step of 2 fs. The SHAKE algorithm (Ryckaert
et al., 1977) was used to constrain all the bonds involving H atoms
at their equilibrium distances. Periodic boundary conditions and
the particle mesh Ewald methods were applied to treat long-range
electrostatic effects (Darden et al., 1993). AMBER ff03 (Duan
et al., 2003), Lipid11 (Skjevik et al., 2012), Lipid14 (Dickson et al.,
2014), and TIP3P (Jorgensen et al., 1983) force fields were used in
all cases.
Analysis of MD Trajectories
The stability of each complex was evaluated by calculating the
root-mean-square-deviation (RMSD) of the Cα atoms along
the trajectories, using their starting structures as reference.
Additionally, the root-mean-square-fluctuation (RMSF) of each
residue, relative to the corresponding average value, was
calculated once each snapshot had been fitted to its initial
structure. The effective binding free energies between the
ligands and the more relevant residues in the binding site were
qualitatively estimated using the MM/GBSA (Miller et al., 2012;
Genheden and Ryde, 2015). MM/GBSA is a popular approach
to estimate the free energy of the binding of small ligands
to biological macromolecules. MM/GBSA takes into account
a MM interaction term, a solvation contribution thorough
a generalized born (GB) model, and a surface area (SA)
contribution to account for the non-polar part of desolvation.
The MM part estimates the enthalpic contributions for the
protein–ligand interactions (bonded, electrostatic, vanderWaals).
The polar solvation energy represents the electrostatic interaction
between the solute and the continuum solvent. In addition,
three non-polar solvation terms include cavitation, dispersion,
and repulsion energies, representing the cost of making a cavity
in the solvent, as well as the attractive and repulsive parts
of the van der Waals interactions between the solute and
the solvent. All these three non-polar solvation terms are free
energies and in particular the cavitation energy should have
important entropic components, representing the reorganization
of the solvent around the solute. In summary, in MM/GBSA,
the free energy of a state is estimated from the following sum:
G = Ebnd + Eel + EwdW + Gpol + Gnp − TS. A 12–6 Lennard-
Jones term was used to model de MM contribution. For GB,
the solute dielectric constant was set to four while that of the
solvent was set to 80, and the dielectric boundary was calculated
using a solvent probe radius of 1.4 Å. The polar contribution is
calculated using GB, and the non-polar energy is estimated by
solvent accessible surface area (SASA).
Expression of Transporter cDNA in
Xenopus laevis Oocytes
Wild-type GlyT1 and GlyT1-M475E mutant cDNAs cloned in
pSP64T vector were linearized with XbaI. Wild-type GlyT2
and GlyT2-E650M mutant cDNAs cloned in pAMV vector
were linearized with ClaI. Capped GlyT1 and GlyT2 cRNAs
were transcribed using SP6 and T7 polymerase, respectively
(mMessage mMachine kit, Ambion Inc., TX, United States),
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as described (Gimenez et al., 2012). The oocytes were
harvested from Xenopus laevis females (Xenopus Express,
France) anesthetized in 0.125% (w/v) ethyl 3-aminobenzoate
methanesulfonate (Sigma-Aldrich, St. Louis, MO, United States)
solution in tap water. All the procedures were in accordance with
the Spanish and European guidelines for the prevention of cruelty
to animals. Oocytes were defolliculated by 1 h treatment with
300 U/ml collagenase (Type 1, Sigma-Aldrich, St. Louis, MO,
United States) in a solution containing (in mM): 82.5 NaCl, 2 KCl,
1 MgCl2, 5 Hepes, pH 7.4. Fifty nanograms mRNAs were injected
into stage V–VI defolliculated oocytes, which were maintained
in Barth’s medium (in mM): 88 NaCl, 1 KCl, 0.33 Ca(NO3)2,
0.41 CaCl2, 0.82 MgSO4, 2.4 NaHCO3, and 10 HEPES, pH 7.4.
Experiments were performed 3–6 days after injection.
Two-Microelectrode Voltage-Clamp
Recordings From Xenopus laevis
Oocytes
Two electrode voltage clamp was used to measure and control
the membrane potential and to monitor the capacitative currents
using Axoclamp 900A, digitized using a Digidata 1440. Both
instruments were controlled by pCLAMP software (Axon
Instruments, Foster City, CA, United States), and the results
were analyzed using Clampfit 10.3 software (Molecular Devices).
Recordings from oocytes were performed at 18◦C using standard
micropipettes filled with 3 M KCl (resistance < 1 M) (Gimenez
et al., 2012). All electrophysiological recordings were performed
in oocytes held at −60 mV (unless otherwise stated in the
figures) using a recording solution, containing (in mM): 100
NaCl, 2 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, pH 7.4. In ion
substitution experiments, Na+ was isosmotically replaced by
choline chloride. In Cl− free recordings, Cl− was fully replaced
using (in mM): 100 chloride gluconate, 2 KNO3, 1 Ca(NO3)2,
1 MgSO4, 10 HEPES, pH 7.4. For ERev measurements, the
oocytes were inject prior to recording with 18 nl of solutions
containing either glycine (1 M) alone ore glycine (1 M) and NaCl
(1 M). After injection oocytes were superfused with solutions
containing different external sodium concentrations (chloride
and glycine external concentrations remained constant). For
any given external Na+ concentration current-voltage (I–V)
measurements were recorded at 100 µM external glycine in the
absence and presence of extracellular ALX-1393 (5 µM) to yield
the net glycine-evoked currents.
Ethics Statement
This study was carried out in accordance with the principles of
the Basel Declaration and recommendations of the European
Community Council Directives. All biosafety procedures and
animal care protocols were approved by the bioethics committee
for the research from the Universidad Autónoma de Madrid
(UAM), Madrid, Spain and the CBMSO Animal Experimentation
Ethics Committee, Madrid, Spain.
Data Analysis
Non-linear regression fits of experimental data and statistical
analysis were performed with GraphPad Prism 6.01 (GraphPad
Software Inc., San Diego, CA, United States). Bars represent
S.E.M. of at least triplicate determinations. Representative
experiments are shown that were repeated at least three times
with equivalent results.
RESULTS
GlyT2 dDAT Homology Model
An outward-facing tridimensional model of GlyT2 was built
using the crystalized dDAT structure [PDB code 4M48 (Penmatsa
et al., 2013)] as template (Figure 1A). This DAT structure was
crystalized with two bound sodium ions and one chloride ion
(Penmatsa et al., 2013). In the resulting GlyT2 model the glycine
binding site (S1 site) was conserved as compared to previous
GlyT2 models based on LeuTAa, supporting the participation
of Gly212, Leu213, Tyr289, Ser481, and Thr580 in substrate
recognition or translocation (Perez-Siles et al., 2011). The
involvement of these residues has been validated by mutagenesis
and functional assays (Rees et al., 2006; Perez-Siles et al., 2011,
2012; Carland et al., 2017). The carboxyl moiety of the substrate
(glycine) coordinates the sodium ion bound at the Na1 site
(Yamashita et al., 2005; Penmatsa et al., 2013). For this reason,
the mutagenesis of many Na1 site coordinating residues (Ala210,
Asn215, Phe478, Ser479, Leu480, Ser481, and Asn511) strongly
increased Kmgly of glycine transport (Perez-Siles et al., 2011,
2012). Na1 and Na2 sites were conserved as well, being Na2 site
contributed by Gly208, Val211, Leu576, and Asp579 (Perez-Siles
et al., 2011, 2012). The residue Asp471 previously identified as
a transitory cation binding site in the extracellular vestibule of
GlyT2 (Perez-Siles et al., 2012) conserved the same position in the
revised model. In addition, the chloride site, clearly visualized in
dDAT, was conserved in the new GlyT2 model (Supplementary
Figure S1A and see below).
The obtained GlyT2 dDAT homology model was inserted in
a pre-equilibrated lipid bilayer box and was further optimized
and tested for stability by means of 50 ns MD simulations in
the presence of all the substrates: glycine, three sodium ions, and
a chloride ion. In order to accommodate the third sodium ion
(Na3 site of GlyT2), absent in dDAT, we considered two possible
locations displaying crystalographic water molecules in the SLC6
crystals (Yamashita et al., 2005; Penmatsa et al., 2013; Coleman
et al., 2016). There were one or two water molecules flanking
the unwound TM6 portion in the crystalized structures from the
family, suggesting there is enough free space in the region to
hold a sodium ion (Figure 1A and Supplementary Figure S1B).
In one of such locations (location 1, Figure 1B) sodium would
be coordinated by Tyr209, Glu250, Leu480, and Ser481. The
second position (location 2, Figure 1C), very close to the recently
proposed Na3 site (Subramanian et al., 2016), would involve the
side chains of Glu250 and Glu650 and the back-bone of Ala483
(Supplementary Tables S1, S2). In both cases, the complexes
(protein and substrates) were stable during the 50 ns MD
trajectories showing root-mean-square-deviation (RMSD) lower
than 3Å in location 1, and up to 4Å in location 2 (Figure 1D). The
RMSD changes depicted in Figure 1D after approximately 15 ns
implied a displacement of the third Na+ located at position 2. The
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FIGURE 1 | (A) GlyT2 dDAT homology model. Left: PyMol-generated GlyT2 lateral view is shown in a cartoon representation with conserved Na1 and Na2 as
purpled spheres and chloride ion as green sphere. The water molecules found in several NSS crystals (red spheres) are surrounding the unwound portion of TM6.
Right: structure alignment in PyMol of GlyT2 model, LeuTAa and dDAT crystals. 90% of the LeuTAa and dDAT crystals in PDB show 2 crystallographic water
molecules in locations 1 and/or 2. The three structures are shown as ribbon, GlyT2 model is colored in orange, LeuTAa in green, and dDAT in cyan. The waters are
depicted as red spheres and residues Glu250 and Glu650, which bind waters, are shown in stick representation. (B) Interaction matrix and lateral view of Na3
placed in location 1. (C) Interaction matrix and lateral view of Na3 placed in location 2. Cations are shown as purple spheres. Residues are shown in stick
representation. (D,E) Root-mean-square-deviations (RMSD) (D) and energy profile (E) along the 50 ns MD simulations with sodium placed in location 1 or 2.
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stability of the ion after relocation suggests stronger coordination.
The mean calculated interaction energy value for glycine in the
last ns of the dynamics was 1E = −33.2 and −32.5 kcal/mol
for structures containing Na3 in locations 1 and 2, respectively
(Supplementary Figure S2B). The energy values for the binding
of sodium in Na3 site were in kcal/mol −3.4 (location 1) and
−8.85 (location 2, Figure 1E). This suggests a more favorable
position for sodium in location 2 conceivably stabilized by the
electrostatic interaction with Glu250 and Glu650 (Figure 1C).
The stability of the glycine binding site was maintained during
the MD simulations with similar RMSD values and comparable
energy profiles regardless of the location occupied by the third
sodium (Supplementary Figure S2A). Closer inspection of the
glycine binding site across the simulations revealed that the use
of the dDAT template independently of the Na3 position resulted
in the emergence of new coordinating residues (Supplementary
Figures S2C,D). The presence of Na3 in location 2 enabled the
reorientation of Ala210, Val211, Gly214, Phe478, and Trp484
to the substrate (Supplementary Tables S3, S4). These amino
acids were predicted (and some confirmed) (Perez-Siles et al.,
2011; Carland et al., 2017) to belong to the glycine site (Rees
et al., 2006; Carta et al., 2012). Besides, Tyr209 is involved in
the stabilization of the unwound TM6 region and the Na2 site
through a conservative backbone hydrogen bond with Ser481
within the crystals. Placing Na3 in location 1 may disturb Tyr209
interactions. Therefore, our data point to location 2 as more
suitable for Na3 accommodation.
Functional Analysis of Glu250 and
Glu650 Mutants
A MSA of several NSS transporters (Figure 2A) illustrates GlyT2
Glu250 is totally conserved within the family (including GlyT1
Glu89) but GlyT2 Glu650, although present in other members,
is non-conservatively substituted by methionine (Met475) in
GlyT1. The structural alignment of GlyT1 and GlyT2 models
based on dDAT shows the voluminous Met475 reducing the free
space in GlyT1 as compared to Glu650 in GlyT2 (Figures 2B,C).
This condition, together with the absence of the coordinating
oxygen in the methionine side chain might prevent the formation
of a cation binding site in GlyT1. To test this hypothesis, we
mutated the predicted main coordinating residues in location
2 (Glu250 and Glu650) and studied mutant properties once
expressed in COS7 cells. The mutants used in this study
were GlyT2-E650M and its reverse mutant GlyT1-M475E; the
aspartate substitutions GlyT2-E650D and GlyT1-M475D; the
GlyT2-E250D and the double mutant GlyT2-E250A/E650M. All
the mutants were delivered to the plasma membrane, as assessed
by surface biotinylation (Figures 2D,E). The main effect of the
substitution in every wild-type transporter was a reduction in the
plasma membrane expression and the corresponding decrease
in glycine transport. One exception was the double mutant,
for which the transporter fraction that reached the surface
approached the level of wild-type GlyT2. Moreover, the double
mutant showed no apparent phenotype (Table 1). Nonetheless,
all the mutations were tolerated, and the levels of transport
were sufficient for subsequent studies. Every mutant used in
this study was properly inhibited by the corresponding specific
inhibitor of GlyT1 (NFPS) or GlyT2 (ALX1393), indicating
correct folding and general structure (not shown). In contrast,
GlyT2 point substitutions involving Glu250 other than E250D
(substitutions to A, T, and Q) were not functional, and the
reciprocal mutant GlyT1-E89D was inactive despite it reached
the surface. Lastly, with the exception of GlyT2-E250A/E650M,
GlyT2 double mutations affecting Glu250 plus Glu650 could
not be analyzed because the mutants did not reach the plasma
membrane (substitutions to D/M; T/D; D/D; or T/M were
assayed, not shown).
Kinetic parameters of glycine transport by active mutants are
shown in Table 1. The main feature of GlyT2 single mutants
was a reduction in Vmax (about 30–40% of wild-type), whereas
GlyT1 mutants mainly showed increases in Km (about two to
threefold). Diminished Vmax was also detected in GlyT1-M475E.
The ratio Vmax/Km was reduced in every mutant: 15–40%
(GlyT2 mutants) and 70–80% (GlyT1 mutants), suggesting that
glycine transport was less altered by the mutations in GlyT2 than
in GlyT1 background.
The above mutants were tested for sodium dependence of
glycine transport (Figure 3). Single or double GlyT2 mutants
including Glu250 substitutions showed significantly reduced
sodium affinity as well as diminished Hill coefficient that
reached significance in the GlyT2-E250A/E650M double mutant
(Figures 3A–C). For GlyT1, Met475 substitution mutants
showed reduced apparent Na+ affinity, which was significantly
lower than wild-type (EC50Na+ in mM: 192.8 ± 41.8, n = 4;
127.6 ± 17.3, n = 3 vs. 65.5 ± 9.8, n = 7 for GlyT1-
M475D, GlyT1-M475E, and wild-type GlyT1). In addition, both
Met475 substitution mutants showed significant increases in
the Hill coefficient (n) (1.63 ± 0.18 vs. 2.50 ± 0.31 and
2.66 ± 0.25 for wild-type GlyT1, GlyT1-M475E, and GlyT1-
M475D, respectively, Figures 3D–F).
Electrophysiological Characterization of
Glu-250 and Glu-650 Mutants in Xenopus
laevis Oocytes
We explored the electrophysiological properties of the above
mutants assayed in Xenopus oocytes. Some of the mutants
that were active in COS7 cells did not generate currents
(GlyT2-E250D, GlyT2-E650D, GlyT1-M475D, and GlyT2-
E250A/E650M, not shown). In contrast, the application of 1 mM
glycine to oocytes expressing GlyT2-E650M, GlyT1-M475E,
or the wild-type transporters clamped at −60 mV induced the
appearance of robust inward currents of increased amplitude
as the external sodium concentration was elevated and reached
saturation (Figures 4A–D). Glycine-evoked currents were
measured at different holding potentials over the range of –150
and –10 mV (Figure 5). The Na+ dependence of the normalized
currents fit to the Hill equation for individual potentials allowed
estimating EC50 and Hill coefficient. The estimated parameters
in oocytes at saturating glycine concentrations (1 mM) replicated
the tendency in COS7 cells although the reduction in EC50
and Hill coefficient of the E650M mutant reached significance,
perhaps due to the saturating glycine concentrations that can
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FIGURE 2 | GlyT1 and GlyT2 alignment and mutant expression. (A) Alignment of the amino acid sequences of TM2 and TM10 of rat NSS transporters using the
ClustalW program. (B,C) Structural alignment of modeled GlyT1 and GlyT2 showing GlyT2 Glu250 and Glu650 and GlyT1 Glu89 and Met475 in stick representation.
(D,E) Surface expression of GlyT2 (D) and GlyT1 (E) mutants assessed by surface biotinylation. T, total transporter; B, biotinylated transporter; TfRc, transferrin
receptor as loading control.
be used in oocytes but not in cells where basal glycine transport
due to low affinity GlyTs obligates using low µM concentrations.
On the contrary, the GlyT1-M475E mutant kept displaying
higher EC50 and Hill values than GlyT1 (Figures 5E,F). The
glycine-induced steady-state currents by oocytes expressing
wild-type transporters were non-reversing inward currents
(Figures 6A,B), reflecting electrogenic Na+-coupled glycine
influx. As reported, GlyT2 currents showed higher inward
rectification than those of GlyT1 (Lopez-Corcuera et al., 1998;
Roux and Supplisson, 2000). Quantification of the rectification
degree indicated the GlyT2-E650M mutant displayed reduced
rectification as compared to GlyT2 wild-type (Figures 6A,C),
although non-significant difference with GlyT1was exhibited
by the GlyT1-M475E mutant (Figures 6B,D). No reversion of
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TABLE 1 | Kinetic parameters of glycine transport by GlyT2 and GlyT1 mutants in
transfected COS7 (150 mM NaCl).
Mutant Vmax (nmol/mg/10 min) Km (µM) Vmax/Km
wtGlyT2 32.5 ± 8.7 133.5 ± 25.7 0.24 ± 0.04
E250D 14.2 ± 3.9 92.6 ± 6.7 0.16 ± 0.04
E650D 11.8 ± 4.3 66.7 ± 25.9 0.18 ± 0.03
E650M 17.7 ± 7.2 102.4 ± 33.7 0.15 ± 0.03
E250A/E650M 35.8 ± 19.1 177.2 ± 103.4 0.21 ± 0.01
wtGlyT1 114.6 ± 11.1 199.9 ± 35.0 0.62 ± 0.17
M475D 91.3 ± 0.5 630.0 ± 163.7 0.17 ± 0.04
M475E 45.6 ± 17.5 542.6 ± 168.9 0.12 ± 0.05
the currents was observed for any transporter, suggesting they
are transport-associated stoichiometric currents. We compared
the time integral of the glycine-induced current (charge) with
the simultaneous [3H]-glycine uptake (flux) for each transporter
to estimate the net number of charges translocated when the
oocytes were clamped at hyperpolarizing potentials (Figure 6E).
As previously reported, GlyT2 moves two positive charges
per transported glycine molecule (Roux and Supplisson, 2000;
Vandenberg et al., 2007) and, accordingly, it gave a charge-to-flux
ratio of 2.30 ± 0.19, n = 10 at −60 mV. At this potential, our
measurements on GlyT2-E650M gave a ratio of 1.03± 0.19, n = 6,
what was significantly lower to wild-type GlyT2 and similar to
that of wild-type GlyT1 (1.23 ± 0.13, n = 17), which translocates
1 charge per transport cycle (Roux and Supplisson, 2000;
Vandenberg et al., 2007; Perez-Siles et al., 2012; López-Corcuera
et al., 2017) (Figure 6E). Interestingly, the charge-to-flux ratio of
GlyT2-E650M was also significantly lower than wild-type GlyT2
in oocytes clamped at −100 mV (3.29 ± 0.6, n = 4 for GlyT2
and 1.38 ± 0.2, n = 5 for E650M) (Figure 6F), in agreement
with a fixed stoichiometry of glycine transport (Sonders et al.,
1997). These data suggest that the substitution of Glu650 by
methionine impairs the ability of GlyT2 to hold the third sodium
ion. Conversely, the acidic substitution of Met475 in GlyT1
does not increase sodium coupling since the charge-to-flux
ratio for GlyT1-M475E mutant (0.91 ± 0.15, n = 8) indicates
the mutant is able to translocate only one charge per transport
cycle as wild-type GlyT1. Although the estimated Hill coefficient
and the charge-to-flux ratio suggested GlyT2-E650M may
cotransport a lower number of Na+ ions, a further approach
to the direct evaluation of its stoichiometry was obtained by
determining the equilibrium potential of the transporter (ET)
or ERev as a function of the external sodium concentration
([Na + ]o). The GlyT2 ERev is the membrane potential at which
transport is in thermodynamic equilibrium (not inward or
outward transport) and it depends on the ionic and substrate
electrochemical gradients as indicated by the thermodynamic
relationship:
ET = 2.3R T





To obtain measurements of the ERev of the wild-type and
mutant transporters, both inward and outward currents must
be measured in the same oocyte, so it is necessary to decrease
the driving force. It has been demonstrated that coinjection
of glycine and NaCl is necessary to evoke outward currents
in GlyT2-expressing oocytes whereas injection of glycine alone
was sufficient to evoke outward currents in GlyT1 (Roux and
Supplisson, 2000). When we set up the experimental conditions,
we confirmed the injection of glycine and NaCl was necessary for
GlyT2 reversion but glycine alone was sufficient to evoke outward
currents in GlyT2-E650M, so that we established these conditions
for the determination of the ERev of the two transporters.
As the extracellular Na+ concentration was increased, ERev
shifted to more positive membrane potentials (Figures 7A,C).
A plot of ERev as a function of log [Na+]o revealed a slope of
86.49 ± 11.05 mV (n = 7–9) for a tenfold change in [Na+]o
for GlyT2 (Figure 7B). This value almost coincides with the
predicted change in ERev at 18◦C (86.50 mV for zT = 2), and
gives nNa = 2.99 for GlyT2. For GlyT2-E650M, the slope was
113.50 ± 12.10 mV (n = 5–13), very close to the theoretical
prediction of 115.36 mV for 2Na+:1Cl−:1gly stoichiometry,
giving nNa = 1.97 for zT = 1 (Figure 7D). These data suggest that
GlyT2-E650M mutant could translocate one less Na+ ion during
the transport cycle.
Molecular Dynamics Simulations of
GlyT2-E650M
To analyze the effect of E650M mutation on the modeled GlyT2
structure, we performed 50 ns MD simulation of the mutated
structure (Supplementary Figure S3). The dynamics was started
with Na3 placed in location 2. During the first ns, Na3 jumped
from its initial position and moved toward Glu250, losing the
interaction with the position 650 where the glutamate was
mutated to methionine (Supplementary Figures S3A,C). The
mutant dynamics started with unfavorable positive initial energy
values indicating repulsive energy, which become less repulsive
as the dynamics progressed due to the entry of water molecules
solvating Na+ in location 2 (Supplementary Figure S3B).
However, energy values were always very close to zero. After
approximately 20 ns of simulations, repulsive interactions
appeared between Na+ and the surrounding residues. There was
an important lose in electrostatic interaction energy (1E = −0.6
vs. −8.85 kcal/mol, see above), indicating the absence of Glu650
makes the binding of Na3 in location two non-favorable.
Although the structural and energetic stability of the binding of
substrate and the rest of ions to the mutant transporter were
comparable to that of the wild-type GlyT2 model, according to
the ability of the mutant to display about 50% wild-type glycine
transport, it is evident the mutation energetically influences the
putative Na3 site.
Allosteric Effects of Putative Na3 Site
Mutants
The above data suggest Glu650 (together with Glu250) is a
key residue for the sodium coordination in the putative GlyT2
Na3 site. These two glutamates align with Glu419 (TM10)
and Glu62 (TM2) in LeuTAa, which are residues sensitive to
the differential ion-specific conformational changes transmitted
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FIGURE 3 | Sodium dependence of glycine transport by GlyT2 and GlyT1 substitution mutants. COS7 cells expressing the indicated transporters were assayed for
glycine transport in the presence of increasing extracellular NaCl concentrations (isotonic substitution by choline chloride). Control glycine transport by wild type
GlyT2 and GlyT1 were 2.0 ± 0.06 and 5.49 ± 0.26 nmol glycine/mg protein/10 min, respectively. (A,D) Representative experiments are shown that were repeated at
least three times performed in triplicate. Glycine transport has been Vmax normalized. Experimental data were fitted to the Hill equation. (B–F) EC50 for sodium and
Hill coefficient were determined and analyzed by one-way ANOVA with Dunnett’s post hoc test, comparing with wild-type GlyT1 and GlyT2. p > 0.05; ∗p < 0.05;
∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001. For mutants nonsaturated at 150 mM NaCl, determinations up to 300 mM NaCl were performed.
through the TM10-TM6 interface upon the binding of sodium
or lithium (Zhao et al., 2011). Since lithium exerts differential
effects in the activity of the GlyTs (Perez-Siles et al., 2011,
2012), we analyzed the response to lithium ion on glycine
transport by the putative Na3 site mutants. In agreement with
our previous data, Figures 8A,B shows that the effect of lithium
in COS7 cells expressing GlyT2 was stimulatory, whereas it
exerted a noncompetitive inhibitory effect on GlyT1 transport.
Conversely, the GlyT2-E650M and the GlyT1-M475E mutants
displayed an inverted tendency as compared to their wild-types.
These data suggest that the ion-specific local interactions in
the vicinity of these particular TM10 residues can be emulated
by the substitutions. It is also possible that the conformational
changes induced at TM10 can propagate to the ion-binding sites
(Kantcheva et al., 2013).
Chloride Dependence of Putative Na3
Site Mutants
The role of the TM6-TM10 interface in the propagation of the
conformational changes induced by Na+ binding (Zhao et al.,
2011) prompted us to investigate the effect of mutations in the
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FIGURE 4 | Glycine-associated currents of GlyT2 and GlyT1 substitution
mutants at different external sodium concentrations. (A–D) Inward currents
recorded at a holding potential of –60 mV elicited by application of 1 mM
glycine at the indicated sodium concentrations (extracellular NaCl
concentrations isotonically substituted by choline chloride) in four
representative oocytes expressing the indicated transporters.
putative Na3 site on the chloride dependence. We measured
the current-voltage relation of the wild-type GlyT2 and the
GlyT2-E650M mutant in regular recording medium containing
100 mM NaCl (Figure 9A) or the same medium where the
chloride was isosmotically substituted (nominally zero chloride,
see Materials and Methods) (Figure 9B). Normalized wild-type
and mutant currents were almost identical when measured in
external medium containing NaCl (Figure 9A). In the nominal
absence of chloride, outward currents were evident in the two
transporters though the amplitude was higher in the mutant
(Figure 9B). The ERev around −10 mV suggests proton or
cation diffusion in the absence of chloride (Mager et al., 1994;
Sonders et al., 1997; Longpré et al., 2010). To further confirm
this observation, we measured glycine transport by COS7 cells
expressing GlyT2-E650M mutant in the presence of increasing
chloride concentrations (NaCl isosmotically substituted by
sodium gluconate). As depicted in Figure 9C, transport by
the mutant showed about 50% reduction at zero-chloride, and
slightly increased at higher Cl− concentrations. For comparison
we analyzed GlyT2-S515E. In this mutant, the serine that
aligns with Glu290 in LeuT, which is the residue responsible
for the chloride independence of transport by prokaryote NSS
members, is substituted to glutamate (Zomot et al., 2007). The
introduction of a negative charged amino acid at or near the
two sodium-binding sites of several NSS transporters renders
transport chloride-independent (Zomot et al., 2007; Ben-Yona
et al., 2011; Kantcheva et al., 2013). In fact, GlyT2-S515E and
the equivalent mutation in GlyT1 (S339E) almost abolished
the chloride dependence of transport (Figures 9C,D). Glycine
transport by GlyT2-E650M was mostly unaltered in the presence
of increasing chloride concentrations similarly to GlyT2-S515E
and opposite to wild-type GlyT2. However, this feature was not
observed for the reverse mutant GlyT1-M475E whose hyperbolic
dependence on chloride was very similar from that of wild-
type and differed from that of GlyT1-S339E (KmCl− 33 ± 6
and 49 ± 4 mM for GlyT1 and GlyT1-M475E, respectively,
Figure 9D). These results suggest the E650M mutation in GlyT2,
but not the reverse mutation M475E in GlyT1, generates allosteric
effects on the chloride-binding site. We hypothesized the removal
of Glu650 could leave unpaired the Glu250, which may fulfill pKa
requirements to affect the chloride site. If this hypothesis was
correct, the simultaneous removal of Glu650 and Glu250 could
restore chloride dependence of transport. We, therefore, analyzed
the chloride dependence of glycine transport by the double
mutant GlyT2-E250A/E650M and found it was indistinguishable
from that of wild-type (KmCl− 25 ± 4 and 24 ± 3 mM for
GlyT2 and GlyT2-E250A/E650M, respectively), indicating the
simultaneous mutation of the two glutamates completely rescued
the chloride dependence of transport to the wild-type phenotype
(Figure 9C).
DISCUSSION
The recent resolution of eukaryotic crystals of the SLC6 family
has provided new three-dimensional structures for modeling
the GlyTs. We previously validated GlyT models using the
prokaryotic LeuTAa template (PDB 2A65) (Yamashita et al., 2005)
using site directed mutagenesis and confirmed the conservation
of the substrate and two sodium sites (Na1 and Na2) in the GlyTs
(Perez-Siles et al., 2011, 2012). By profiting the availability of
crystalized structures with higher homology to the GlyTs, here
we have generated and validated homology models using the
Drosophila melanogaster DAT crystal as a template (PDB 4M48)
(Penmatsa et al., 2013). A dDAT-based modeled structure was
lately used by others to propose the location of the GlyT2 Na3
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FIGURE 5 | Sodium dependence of glycine-evoked steady-state currents in the oocytes expressing GlyT2 and GlyT1 wild-type and mutants. (A–D) At least six
oocytes expressing the indicated transporters were voltage-clamped at the specified clamping potentials over the range of –150 and –10 mV and glycine-induced
currents at increasing external sodium concentrations (choline substitution) were measured to estimate the EC50 (E) and Hill coefficient (F). At each potential
glycine-induced currents were averaged and normalized to those at –150 mV. Data were analyzed by paired t-test, comparing with wild-type GlyT1 or wild-type
GlyT2. ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
site, absent in the template, by MD simulations in which the Na+
ion was placed at the homologous position to that of the Na1′ site
of the betaine transporter BetP. Several queries were raised on the
stability of this proposed sodium binding site since the eventually
obtained sodium site was spatially separated from the BetP Na1′
site due to ion jumping along the simulation (Subramanian et al.,
2016).
In order to settle the location of the third Na+ site in GlyT2, we
initially tested two possible Na3 accommodations in the dDAT-
based GlyT2 model. These positions displayed crystallographic
water molecules in the available NSS crystals (Yamashita et al.,
2005; Penmatsa et al., 2013; Coleman et al., 2016). The MD
simulations we performed indicated higher stability and lower
interaction energy values for Na3 binding when located close to
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FIGURE 6 | Glycine-induced steady-state currents and charge-to-flux ratios by wild-type GlyTs and mutant transporters. (A–D) Glycine-induced currents: the
membrane voltage of oocytes expressing the indicated transporters was stepped from a holding potential of –60 mV to voltages between –150 to 30 mV in –20 mV
increments. Currents in 100 mM NaCl recording solution were subtracted from those in the same medium supplemented with 1 mM Gly. At each potential
glycine-induced currents were averaged and normalized to those at –150 mV. These currents were then plotted against the corresponding potential (millivolt). The
data are the mean ± SEM (error bars) of at least four different oocytes. Wherever error bars are not visible, the error was smaller than the size of the symbols. The
mean currents at –150 mV induced by 1 mM glycine were –67.6 ± 6.7 nA in GlyT2, –34.8 ± 2.7 nA in GlyT2-E650M, –132.1 ± 19.2 nA in GlyT1, and –77.6 ± 23.9
in GlyT1-M475E. The rectification degree has been estimated as the ratio of the slopes of the linear regression fit of the three current values at the most negative and
most positive potentials in the I/V curves. The calculated rectification degree at 100 mM NaCl are 4 (GlyT2), 1.75 (GlyT2-E650M), 1.3 (GlyT1), and 1 (GlyT1-M475E).
(E,F) charge-to-flux ratios: oocytes expressing the indicated transporters were voltage-clamped at –60 mV (E) or –100 mV (F) in 100 mM NaCl recording solution
and the current induced by 30 µM radioactive glycine (0.4 Ci/mmol) was measured for 1 min. The charge moved during this time was obtained by integrating the
current over time (Clampfit v. 10.3). The ratio was determined by calculating the moles of charge and dividing by the moles of radiolabeled substrate taken up as
determined from scintillation counting after correction by the values for non-injected oocytes. The data are given in mean ± SEM (error bars) of at least four different
oocytes. ∗∗∗∗p < 0.0001 one-way ANOVA with Bonferroni’s multiple comparison test, ∗p < 0.05 Mann–Whitney test.
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FIGURE 7 | Reversal potential of wild-type and GlyT2-E650M mutant-mediated currents as a function of the external Na+ concentration. (A,B) GlyT2 oocytes
injected with 18 nM of glycine and NaCl: current-voltage relationships (A) and ERev plotted as a function of the log [Na+]o (B). (C,D) GlyT2-E650M oocytes injected
with 18 nM of glycine: current-voltage relationships (C) and ERev plotted as a function of the log [Na+ ]o (D). Linear regression equation is presented in the graphs.
FIGURE 8 | Lithium dependence of glycine transport of wild-type GlyTs and mutant transporters. (A,B) COS7 cells expressing wild-type GlyT2 or GlyT2-E650M (A)
or wild-type GlyT1 or GlyT1-M475E (B) were assayed for 3[H]-glycine transport in HBS containing 30 mM NaCl concentration in every point and the indicated
increased LiCl concentration up to 150 mM that was reached by isotonic supplementation with choline chloride. ∗p < 0.05 Mann–Whitney test.
the proposed Na3 site (Subramanian et al., 2016), although our
simulations excluded Met278 (IL1) and Trp265 (TM3), which
were included in that study perhaps due to some incipient
transition toward the inward conformation during simulations.
Among the residues contributing to the putative Na3 site, the
unique non-conservative substitution between GlyT2 (3 Na+
sites) and GlyT1 (2 Na+ sites) is Glu650 (TM10) in GlyT2, which
is replaced by a methionine (Met475) in GlyT1. Among the NSS
transporters most are coupled to two Na+ ions although there
are some coupled to one Na+ ion. In SERT, it has been proven
that Na+ binds to Na1 and Na2 and generates conformational
changes in both of them, but only the Na+ ion bound to Na2 is
translocated (Felts et al., 2014). This indicates that the presence
of a sodium site may not have consequences in stoichiometry,
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FIGURE 9 | Chloride dependence of glycine-induced steady-state currents and glycine transport by wild-type GlyTs and mutant transporters. (A,B) Glycine-induced
currents: the membrane voltage of oocytes expressing the indicated transporters was stepped from a holding potential of –60 mV to voltages between –150 to
30 mV in –20 mV increments. Currents in 100 mM NaCl recording solution (A) or in chloride-free solution (described in material and methods) (B) were subtracted
from those in the same medium supplemented with 1 mM Gly. At each potential glycine-induced currents were averaged and normalized to those at –150 mV. (C,D)
COS7 cells expressing the indicated transporters were assayed for glycine transport in the presence of increasing extracellular NaCl concentrations (isotonic
substitution by sodium gluconate). Control glycine transport by wild-type GlyT2 and GlyT1 was 3.3 ± 0.3 and 2.6 ± 0.3 nmol glycine/mg protein/10 min,
respectively. Representative experiments are shown repeated at least in three separated experiments performed in quadruplicate. Experimental data were fitted to
the Michaelis–Menten equation.
thus eliminating the requirement of unique residues forming
the third Na+ site. In GlyT2, the residues surrounding the site
could generate an environment that facilitates Na+ binding. As
this environment shows much higher homology with GlyT1 than
with other SLC6 members, GlyT1 could be specifically prevented
from Na+ binding by substituting the sodium-binding oxygen in
the position 650/475 side chain by a methionine.
By site-directed mutagenesis and examination, the sodium
dependence of glycine transport by the mutants, together with
the electrophysiological analysis of mutant currents in Xenopus
laevis oocytes, we obtained evidences that suggest the Na3 ion is
held by Glu650 and Glu250 in GlyT2. The charge-to-flux ratio
for the GlyT2-E650M mutant was reduced as compared to wild-
type GlyT2 to a value comparable to that of GlyT1 even at
strongly hyperpolarizing potentials, thus, suggesting the GlyT2
mutant had reduced sodium coupling compatible with a non-
functional Na3 site. Since other alterations could result in a
change in the charge-to-flux ratio, we determined the ERev as a
function of the external sodium concentration, which agrees with
the prediction for nNa = 2 in GlyT2-E650M mutant in contrast
to wild-type GlyT2. For these measurements glycine and NaCl
were injected into the oocytes. GlyT2 has a kinetic constraint
for reverse transport assuring an asymmetry in glycine fluxes
which is essential to maintain high levels of neurotransmitter
inside the presynaptic neurons. Internal Na+ binding may be
critical in GlyT2 since the injection of glycine alone failed to
activate outward currents. For that reason, it has been proposed
that the third intracellular Na+ site has lower affinity and
limits reverse transport (Roux and Supplisson, 2000). In our
experimental conditions, the reverse transport in GlyT2-E650M
mutant was detected by injecting glycine alone thus increasing
intracellular glycine levels. Since the proposed third sodium site
is more internal than Na1 and Na2 sites, the loss of this site
could facilitate reversal transport. The fact that GlyT1 has a
methionine instead of Glu650 could be related with the absence
of such a limitation for reverse transport. In good agreement,
the rectification of the I/V curves that might reflect the tendency
of GlyT2 to operate in the forward direction and therefore to
show an asymmetry of transport function, is much less evident
in the GlyT2-E650M mutant. However, the rectification degree
obtained for the GlyT1-M475E mutant was not significantly
different from that of GlyT1, according with the incapability of
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this mutant to bind a Na3 ion. Although the ERev as a function of
external glycine and chloride must be determined to confirm the
reduction in translocated sodium ions, the data suggest Glu650 is
a key residue in the maintenance of the transport coupling.
In sodium dependence assays, we estimated the Hill coefficient
(n), which serves as a reliable indicator of transport stoichiometry
only if a very high degree of cooperativity exists between the
binding sites. When all of the cotransported Na+ ions bind with
a positive cooperativity (n > 1) and there are not transporters
partially filled with Na+, the rate of transport varies with
extracellular Na+ concentration depending on nNa. In that cases
fitting to Hill equation will provide a value for n close to nNa
(Prinz, 2010). We found some discrepancies between the value
of n derived from kinetic analysis for GlyT2-E650M and GlyT1-
M475E and our charge-to flux determinations. One possibility
is that, the transport assays in COS7 cells under non-saturating
glycine concentrations did not achieve the maximum transport
rate to obtain a reliable n fitting to Hill equation. That is solved
in oocyte assays where glycine is at saturating concentrations.
However, the increase in GlyT1-M475E Hill coefficient is also
evident in oocytes pointing to the possibility that multiple ions
must bind to the transporter for translocation to occur, but only
one of the ions is actually translocated. In this case, kinetics might
indicate n> 2 even though only two Na+ ions were cotransported
(Rudnick, 1998; Willford et al., 2015).
The behavior of the GlyTs seems to differ from that of
other members of the SLC6 family such as the monoamine
transporters, which show uncoupled or leak currents either
dependent or independent of substrate (Mager et al., 1994;
Sonders et al., 1997; Felts et al., 2014). Moreover, the deletion
of TM10 residues in the GABA transporter GAT1 leads to the
appearance of GABA-induced outward currents and increased
charge-to-flux ratios indicating uncoupled transport (Dayan
et al., 2017). Conversely, all the TM10 mutants analyzed in
this study showed non-reversing inward currents compatible
with coupled glycine influx, and the charge-to-flux ratio of
GlyT2-E650M mutant was lower than wild-type at strongly
negative membrane potentials (−100 mV), though some increase
in the values for both transporters was detected (Figure 6).
Furthermore, in the absence of substrate, we did not measure
significant currents in the presence of sodium or lithium both in
the wild types and the mutants. Moreover, [3H]glycine transport
was always sodium-driven and not lithium-driven. However,
in the absence of chloride in the external medium, we could
measure leak currents both for wild-type GlyT2 and to a higher
extent for the Glyt2-E650M mutant. This suggests there is an
uncoupled current blocked by chloride in the wild-type that is
increased in the mutant. Although no specifically tested, the ERev
of this current close to −10 mV suggests the involvement of
protons or other cations (Mager et al., 1994; Sonders et al., 1997;
Longpré et al., 2010). This feature is remarkable since it has
been reported that chloride independence of NSS transporters
is associated to proton antiport (Zhao et al., 2010). The relation
of this current with stoichiometric transport in the presence of
chloride is presently unknown.
Although predicted in other members of the NSS transporters
(Zhao et al., 2010; Kantcheva et al., 2013; Zhao and Noskov, 2013;
Dayan et al., 2017), our study unveils the robust allosteric
properties of the TM10 region containing Glu650 in GlyT2 but
also Met475 in GlyT1. The substitution of these TM10 residues
affects sodium cooperativity, especially increased in the GlyT1-
M475E mutant. Besides, the wild-type transport responses to
lithium ion are inverted by the substitutions. This suggests the
local interactions generated at the Na2 site, the unique sodium
site where lithium binding may sustain transport in the GlyTs,
are altered (Perez-Siles et al., 2011). The inversion of the lithium
responses in the mutants suggests that only when glutamate
is present at this TM10 position the conformational changes
induced by lithium binding to the Na2 site are favorable to
transport, as takes place in wild-type GlyT2 (Perez-Siles et al.,
2012). Our results confer this TM10 region of the GlyTs a role
in the allosteric propagation of the cation binding energy for the
translocation of substrates. Indeed, the allosteric connection of
this region with the S1 (and putative S2) site has been validated in
other NSS members (Zhao et al., 2011). The strong cooperativity
among the sodium sites suggests this region has ideal properties
for the location of the Na3 site in GlyT2 although it might also
sustain a role as a modulatory site or a Na+ exit site.
The substitution of Glu650 in GlyT2 by a neutral amino
acid (Met) present in GlyT1 makes the glycine transport by the
mutant almost chloride-independent. This condition is reversed
by the simultaneous substitution of Glu650 and Glu250 by
neutral amino acids in the double mutant GlyT2-E650M-E250A.
Since it has been demonstrated that the introduction of a
negatively charged amino acid, near the ion-binding sites of
the NSS transporters renders the transport chloride-independent
(Zomot et al., 2007; Ben-Yona et al., 2011; Kantcheva et al.,
2013), we propose it is the negative charge of the unpaired
Glu250 what alters the chloride dependence in the GlyT2-E650M
mutant. We hypothesize that in the wild-type GlyT2 Glu250
and Glu650 interact with Na+ and in its absence with water
molecules as in other NSS such as LeuTAa (Zhao et al., 2011).
This maintains the two glutamates paired by an electrostatic
interaction. In the GlyT2-E650M mutant, the charge of the
residue in 650 disappears and Glu250 is unpaired. This causes the
introduction of a negative charge near the ion-binding sites what
alters the chloride dependence of GlyT2. In the double mutant
GlyT2-E650M-E250A, the charges from the two glutamates
disappear and there is not remaining unpaired negative charge
that may alter the chloride dependence. For this reason, the
double mutant is chloride-dependent comparable to wild type.
The role of Glu250 as the residue that undertakes protonation-
deprotonation within the transport cycle of the GlyT2-E650M
mutant is reinforced by the fact that Glu250 is included within
the interaction network connecting the ion binding sites (Ben-
Yona et al., 2011; Kantcheva et al., 2013). Indeed our data
could not discard a proton antiport instead chloride symport by
GlyT2-E650M. Conversely, GlyT1 transport remains dependent
on chloride regardless the equivalent position to Glu650 contains
glutamate or methionine, suggesting not only the charge but
the overall transporter structure or the network connecting the
ion binding sites is differential in GlyT1. Our results unveil the
interaction between Glu650 and Glu250 in GlyT2 has differential
properties as compared to GlyT1. This supports an additional
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role for this region in GlyT2 such as a putative sodium-binding
site. In addition, our data suggest the chloride sites in GlyT1
and GlyT2 display unique properties as has been demonstrated
for their extracellular vestibules (Nunez et al., 2000; Perez-
Siles et al., 2012). The residues coordinating the chloride ion
in eukaryotic NSS transporters connect with the external gate
through a hydrogen bond network supporting a role for chloride
in gate closing (Zomot et al., 2007; Kantcheva et al., 2013). We
propose Glu250 and Glu650 have a relevant role in the control of
the closure of the transporter external gate by holding a sodium
ion either transiently or stoichiometrically coupled.
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